Abstract |
Prosaposin (the precursor of saposins A-D) has been identified as a neurotrophic factor in vitro and in vivo. In this study, a novel 11-mer retro-inverso peptidomimetic, Prosaptide D5, was injected i.m. to assess its effectiveness in a rat ischemic model produced by reversible total occlusion of the left middle cerebral artery (MCA). Prosaptide (300 microg/kg, i.m.) injected 3 h after reversible occlusion reduced brain infarct area by 56% compared with a saline group (p < 0.01) at 21 h of reperfusion. A similar injection of D5 6h after occlusion produced a 32% decrease.
|
Authors | A G Lu, D A Otero, M Hiraiwa, J S O'Brien |
Journal | Neuroreport
(Neuroreport)
Vol. 11
Issue 8
Pg. 1791-4
(Jun 05 2000)
ISSN: 0959-4965 [Print] England |
PMID | 10852246
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Nerve Growth Factors
- Neuroprotective Agents
- prosaptide D5
|
Topics |
- Amino Acid Sequence
(genetics)
- Animals
- Brain Edema
(pathology)
- Brain Ischemia
(pathology)
- Cerebral Infarction
(pathology)
- Male
- Molecular Sequence Data
- Nerve Growth Factors
(genetics, pharmacokinetics, pharmacology)
- Neuroprotective Agents
(pharmacokinetics, pharmacology)
- Rats
- Rats, Sprague-Dawley
|